On behalf of our membership, AATB provided comment on the Centers for Medicare and Medicaid Services (CMS) proposed rule addressing Organ Procurement Organizations (OPOs) Conditions for Coverage and Outcome Measure Requirements (Proposed Rule).

On behalf of our membership, AATB filed a Citizen Petition to the Food and Drug Administration (FDA) related to the use of human acellular dermal matrices (hADM) for use in post-mastectomy breast reconstruction procedures.

In order to accurately articulate the size, scope, and positive clinical impact of the tissue banking profession, AATB conducted a survey of US tissue banks in partnership with the US Department of Health and Human Services.